Yahoo Web Search

Search results

    • Why ResMed Stock Is Soaring Today

      Why ResMed Stock Is Soaring Today

      Motley Fool via Yahoo Finance· 20 minutes ago

      ResMed CEO Michael Farrel said on the quarterly earnings call that patients taking these GLP-1 agonists are actually 10.5% more likely to start positive...